NCT03685292 (BSPJ) is a clinical trial of Behavioral Advisory System in Behavioral, sponsored by Brian Bolden.

Who is sponsoring NCT03685292?

NCT03685292 is sponsored by Brian Bolden.

What drugs are being tested in NCT03685292?

Interventions in NCT03685292: Behavioral Advisory System, Behavioral Treatment, Behavioral Division.

What condition does NCT03685292 study?

NCT03685292 studies Behavioral.

Is NCT03685292 still recruiting?

NCT03685292 is currently completed. Last updated 26 September 2018.

Last reviewed 2018-09-26 · How we verify

NCT03685292: BSPJ

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Behavioral Studies and Practices

Completed Last updated 26 September 2018

What this trial tests

trial testing Behavioral Advisory System in Behavioral in 37 participants. Completed in 12 May 2018.

Timeline

1 April 2018

Primary endpoint
30 April 2018

12 May 2018

Quick facts

Lead sponsor	Brian Bolden
Status	Completed
Study type	OBSERVATIONAL
Enrollment	37
Start date	1 April 2018
Primary completion	30 April 2018
Estimated completion	12 May 2018
Sites	1 location across United States

Drugs / interventions tested

Behavioral Advisory System
Behavioral Treatment — full drug profile →
Behavioral Division

Conditions studied

Behavioral — all drugs for Behavioral →

Sponsor

Brian Bolden — full company profile →

Who can join

Adults 19 to 40, any sex, with Behavioral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The focus of this study is to evaluate whether a new fraud material will be suitable for a technological device and or software. \*\*\*For consultation purposes only.\*\*\*

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03685292 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Brian Bolden
Last refreshed: 26 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03685292.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing